SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001701541-24-000030
Filing Date
2024-08-06
Accepted
2024-08-06 07:04:02
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bdtx-20240630.htm   iXBRL 10-Q 865590
2 EX-31.1 exhibit311_q22024.htm EX-31.1 12491
3 EX-31.2 exhibit312_q22024.htm EX-31.2 12265
4 EX-32.1 exhibit321_q22024.htm EX-32.1 9313
  Complete submission text file 0001701541-24-000030.txt   4859554

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdtx-20240630.xsd EX-101.SCH 29113
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bdtx-20240630_cal.xml EX-101.CAL 51844
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bdtx-20240630_def.xml EX-101.DEF 117177
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdtx-20240630_lab.xml EX-101.LAB 496882
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdtx-20240630_pre.xml EX-101.PRE 325145
65 EXTRACTED XBRL INSTANCE DOCUMENT bdtx-20240630_htm.xml XML 613032
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39200 | Film No.: 241177033
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)